The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein

Mara Campioni, Anna Severino, Lucrezia Manente, Ioana L. Tuduce, Stefano Toldo, Michele Caraglia, Stefania Crispi, Michael Ehrmann, Xiaoping He, Jacie Maguire, Maria De Falco, Antonio De Luca, Vijayalakshmi Shridhar, Alfonso Baldi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Hamartin and tuberin are products of the tumor suppressor genes TSC1 and TSC2, respectively. Mutations affecting either gene result in the tuberous sclerosis syndrome, a neurologic genetic disorder characterized by the formation of multiple benign tumors or hamartomas. In this study, we report the identification of TSC2, but not TSC1, as a substrate of HtrA1, a member of the human HtrA family proteins of serine proteases. We show the direct interaction and colocalization in the cytoplasm of HtrA1 and TSC2 and that HtrA1 cleaves TSC2 both in vitro and in vivo. Finally, we show that alterations in HtrA1 expression cause modifications in phosphorylation status of two downstream targets of TSC2: 4E-BP1 and S6K. Our data suggest that, under particular physiologic or pathologic conditions, HtrA1 degrades TSC2 and activates the downstream targets. Considering that HtrA1 levels are significantly increased during embryogenesis, we speculate that one of the targets of HtrA1 activity during fetal development is the TSC2-TSC1 pathway.

Original languageEnglish (US)
Pages (from-to)1248-1260
Number of pages13
JournalMolecular Cancer Research
Volume8
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Inborn Genetic Diseases
Tuberous Sclerosis
Hamartoma
Serine Proteases
Fetal Development
Nervous System Diseases
Tumor Suppressor Genes
Embryonic Development
Cytoplasm
Phosphorylation
Mutation
Genes
Neoplasms
Proteins
In Vitro Techniques
tuberous sclerosis complex 2 protein
tuberous sclerosis complex 1 protein

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Campioni, M., Severino, A., Manente, L., Tuduce, I. L., Toldo, S., Caraglia, M., ... Baldi, A. (2010). The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein. Molecular Cancer Research, 8(9), 1248-1260. https://doi.org/10.1158/1541-7786.MCR-09-0473

The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein. / Campioni, Mara; Severino, Anna; Manente, Lucrezia; Tuduce, Ioana L.; Toldo, Stefano; Caraglia, Michele; Crispi, Stefania; Ehrmann, Michael; He, Xiaoping; Maguire, Jacie; De Falco, Maria; De Luca, Antonio; Shridhar, Vijayalakshmi; Baldi, Alfonso.

In: Molecular Cancer Research, Vol. 8, No. 9, 09.2010, p. 1248-1260.

Research output: Contribution to journalArticle

Campioni, M, Severino, A, Manente, L, Tuduce, IL, Toldo, S, Caraglia, M, Crispi, S, Ehrmann, M, He, X, Maguire, J, De Falco, M, De Luca, A, Shridhar, V & Baldi, A 2010, 'The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein', Molecular Cancer Research, vol. 8, no. 9, pp. 1248-1260. https://doi.org/10.1158/1541-7786.MCR-09-0473
Campioni, Mara ; Severino, Anna ; Manente, Lucrezia ; Tuduce, Ioana L. ; Toldo, Stefano ; Caraglia, Michele ; Crispi, Stefania ; Ehrmann, Michael ; He, Xiaoping ; Maguire, Jacie ; De Falco, Maria ; De Luca, Antonio ; Shridhar, Vijayalakshmi ; Baldi, Alfonso. / The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein. In: Molecular Cancer Research. 2010 ; Vol. 8, No. 9. pp. 1248-1260.
@article{b1f62139653245ee9656a31d20dc675e,
title = "The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein",
abstract = "Hamartin and tuberin are products of the tumor suppressor genes TSC1 and TSC2, respectively. Mutations affecting either gene result in the tuberous sclerosis syndrome, a neurologic genetic disorder characterized by the formation of multiple benign tumors or hamartomas. In this study, we report the identification of TSC2, but not TSC1, as a substrate of HtrA1, a member of the human HtrA family proteins of serine proteases. We show the direct interaction and colocalization in the cytoplasm of HtrA1 and TSC2 and that HtrA1 cleaves TSC2 both in vitro and in vivo. Finally, we show that alterations in HtrA1 expression cause modifications in phosphorylation status of two downstream targets of TSC2: 4E-BP1 and S6K. Our data suggest that, under particular physiologic or pathologic conditions, HtrA1 degrades TSC2 and activates the downstream targets. Considering that HtrA1 levels are significantly increased during embryogenesis, we speculate that one of the targets of HtrA1 activity during fetal development is the TSC2-TSC1 pathway.",
author = "Mara Campioni and Anna Severino and Lucrezia Manente and Tuduce, {Ioana L.} and Stefano Toldo and Michele Caraglia and Stefania Crispi and Michael Ehrmann and Xiaoping He and Jacie Maguire and {De Falco}, Maria and {De Luca}, Antonio and Vijayalakshmi Shridhar and Alfonso Baldi",
year = "2010",
month = "9",
doi = "10.1158/1541-7786.MCR-09-0473",
language = "English (US)",
volume = "8",
pages = "1248--1260",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein

AU - Campioni, Mara

AU - Severino, Anna

AU - Manente, Lucrezia

AU - Tuduce, Ioana L.

AU - Toldo, Stefano

AU - Caraglia, Michele

AU - Crispi, Stefania

AU - Ehrmann, Michael

AU - He, Xiaoping

AU - Maguire, Jacie

AU - De Falco, Maria

AU - De Luca, Antonio

AU - Shridhar, Vijayalakshmi

AU - Baldi, Alfonso

PY - 2010/9

Y1 - 2010/9

N2 - Hamartin and tuberin are products of the tumor suppressor genes TSC1 and TSC2, respectively. Mutations affecting either gene result in the tuberous sclerosis syndrome, a neurologic genetic disorder characterized by the formation of multiple benign tumors or hamartomas. In this study, we report the identification of TSC2, but not TSC1, as a substrate of HtrA1, a member of the human HtrA family proteins of serine proteases. We show the direct interaction and colocalization in the cytoplasm of HtrA1 and TSC2 and that HtrA1 cleaves TSC2 both in vitro and in vivo. Finally, we show that alterations in HtrA1 expression cause modifications in phosphorylation status of two downstream targets of TSC2: 4E-BP1 and S6K. Our data suggest that, under particular physiologic or pathologic conditions, HtrA1 degrades TSC2 and activates the downstream targets. Considering that HtrA1 levels are significantly increased during embryogenesis, we speculate that one of the targets of HtrA1 activity during fetal development is the TSC2-TSC1 pathway.

AB - Hamartin and tuberin are products of the tumor suppressor genes TSC1 and TSC2, respectively. Mutations affecting either gene result in the tuberous sclerosis syndrome, a neurologic genetic disorder characterized by the formation of multiple benign tumors or hamartomas. In this study, we report the identification of TSC2, but not TSC1, as a substrate of HtrA1, a member of the human HtrA family proteins of serine proteases. We show the direct interaction and colocalization in the cytoplasm of HtrA1 and TSC2 and that HtrA1 cleaves TSC2 both in vitro and in vivo. Finally, we show that alterations in HtrA1 expression cause modifications in phosphorylation status of two downstream targets of TSC2: 4E-BP1 and S6K. Our data suggest that, under particular physiologic or pathologic conditions, HtrA1 degrades TSC2 and activates the downstream targets. Considering that HtrA1 levels are significantly increased during embryogenesis, we speculate that one of the targets of HtrA1 activity during fetal development is the TSC2-TSC1 pathway.

UR - http://www.scopus.com/inward/record.url?scp=77957109673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957109673&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-09-0473

DO - 10.1158/1541-7786.MCR-09-0473

M3 - Article

VL - 8

SP - 1248

EP - 1260

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 9

ER -